MYCN and diffuse intrinsic pontine glioma: In the most recent studies, AMXT 1501 plus DFMO showed pronounced anticancer activity in the transgenic mouse models of tyrosine hydroxylase MYC neuroblastoma (TH-MYCN)32 and diffuse intrinsic pontine glioma (DIPG).33